¿Por qué se está usando otra vez la talidomida? Why is thalidomide back?

¿Por qué se está usando otra vez la talidomida? Why is thalidomide back?

En 1998 la Administración Federal para Medicamentos y alimentos de los Estados Unidos de América (FDA) aprobó la comercialización (con restricciones) de la talidomida para el tratamiento del Eritema nodoso asociado a la lepra. Brasil y México también han reglamentado su uso. Dado que actualmente se...

Full description

Bibliographic Details
Main Authors:	Emilio Sanín Pérez, Jorge Mario Gómez Jiménez
Format:	Article
Language:	Spanish
Published:	Universidad de Antioquia 2004-02-01
Series:	Iatreia
Subjects:	Thalidomide teratogenesis antiangiogenesis immunomodulation talidomida teratogénesis antiangiogénesis inmunomodulación
Online Access:	http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/218

Similar Items

Thalidomide Analogs in Brazil: Concern About Teratogenesis / Análogos da Talidomida no Brasil: Preocupação com a Teratogênese
by: Fernanda Sales Luiz Vianna, et al.
Published: (2014-05-01)

Thalidomide Analogs in Brazil: Concern About Teratogenesis
by: Fernanda Sales Luiz Vianna, et al.
Published: (2014-05-01)

Talidomida: indicações em Dermatologia Thalidomide: indications in Dermatology
by: Rubem David Azulay
Published: (2004-10-01)

Prurido braquiorradial tratado com talidomida Brachioradial pruritus treated with thalidomide
by: José Marcos Pereira
Published: (2005-06-01)

Teratogenic effects of lamotrigine on rat fetal brain: a morphometric study
by: Nely Silvia Aragão de Marchi, et al.
Published: (2001-06-01)

Alteraciones del desarrollo embrionario, poliaminas y estrés oxidativo inducidos por plaguicidas organofosforados en Rhinella Arenarum Alterations in embryonic development, polyamines and oxidative stress induced by organophosphates in Rhinella arenarum
by: Cecilia Inés Lascano, et al.
Published: (2009-07-01)

Talidomida usada por pacientes com eritema nodoso hansênico Thalidomide used by patients with erythema nodosum leprosum
by: Maria do Socorro da Silva Valente, et al.
Published: (2010-04-01)

Talidomida no Brasil: vigilância com responsabilidade compartilhada? Thalidomide in Brazil: monitoring with shared responsibility?
by: Maria Auxiliadora Oliveira, et al.
Published: (1999-01-01)

Litio, teratogenicidad y riesgo de recurrencias afectivas durante el embarazo
by: Christian L. Cárdenas-Delgado
Published: (2021-10-01)

Antiteratogenic capacity of Resveratrol in Streptozotocin-induced diabetes in rats
by: Ninna Leslie Trejo-González, et al.
Published: (2015-09-01)

Capacidad antiteratogénica del resveratrol en diabetes inducida por estreptozotocina en ratas
by: Ninna Leslie Trejo-González, et al.

Capacidad antiteratogénica del resveratrol en diabetes inducida por estreptozotocina en ratas
by: Ninna Leslie Trejo-González, et al.

Molecular aspects of the teratogenesis of rubella virus
by: Suji George, et al.
Published: (2019-08-01)

Thalidomide in refractory bleeding due to gastrointestinal angiodysplasias Talidomida en la hemorragia recidivante por angiodisplasias gastrointestinales
by: Antonio Garrido, et al.
Published: (2012-02-01)

Talidomida e mieloma múltiplo: verificação dos efeitos terapêuticos através de parâmetros clínico e laboratoriais Thalidomide and multiple myeloma: therapy evaluation using clinical and laboratorial parameters
by: Rosane Bittencourt, et al.
Published: (2004-12-01)

Antiproliferative and Antiangiogenic Activities of Smenospongine, a Marine Sponge Sesquiterpene Aminoquinone
by: Hongquan Duan, et al.
Published: (2011-01-01)

Talidomida, contextos históricos y éticos Thalidomide, historical and ethical contexts
by: José Ángel Chávez Viamontes, et al.
Published: (2009-12-01)

Teratogenic effect of cadmium: From the developing embryo to the fetus
by: Juan Sebastián Calle, et al.
Published: (2015-06-01)

The ethanolic extract of Salvia lachnostachys Benth is not maternotoxic, does not alter reproductive performance, but has teratogenic potential
by: Hudman Cunha Ortiz, et al.
Published: (2023-05-01)

Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma
by: Cedric Brackenier, et al.
Published: (2023-01-01)

Antiangiogenic effect of betamethasone on the chick cam stimulated by TA3 tumor supernatant
by: DAVID LEMUS, et al.
Published: (2001-01-01)

Thalidomide: from tragedy to promise
by: R Stolz
Published: (2003-02-01)

Molecular Response to Toxic Diatom-Derived Aldehydes in the Sea Urchin Paracentrotus lividus
by: Stefano Varrella, et al.
Published: (2014-04-01)

Risks associated with psychotropic drugs during pregnancy
by: Supriya Agarwal, et al.
Published: (2018-01-01)

<b>Chlorophyllin in the intra-uterine development of mice exposed or not to cyclophosphamide</b> - doi: 10.4025/actascihealthsci.v35i2.12470
by: Vessia Silva Leite, et al.
Published: (2013-06-01)

A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies
by: Joan How, et al.
Published: (2022-05-01)

Effects of betamethasone, sulindac and quinacrine drugs on the inflammatory neoangiogenesis response induced by polyurethane sponge implanted in mouse
by: JULIO ILLANES, et al.
Published: (2002-01-01)

Effects of Steroidal and Non Steroidal Drugs on the Neovascularization Response Induced by Tumoral TA3 Supernatant on CAM from Chick Embryo
by: JORGE ZÚÑIGA, et al.
Published: (2003-01-01)

The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis
by: Domenico Ribatti
Published: (2010-03-01)

Asymptotic dynamics of an anti-angiogenic system in tumour growth
by: Xue Yu, et al.
Published: (2021-04-01)

Kochia scoparia seed extract suppresses VEGF-induced angiogenesis via modulating VEGF receptor 2 and PI3K/AKT/mTOR pathways
by: Hyun-Dong Cho, et al.
Published: (2019-01-01)

Combining Bevacizumab with Endostatin Gets Better Antitumor Efficacy in Vivo  in Lung Cancer Animal Model
by: Niu NIU, et al.
Published: (2013-02-01)

Talidomida
by: Manuel Fernando Queiroz dos Santos Junior., et al.
Published: (1981-11-01)

Comparative Genomics Identifies Putative Interspecies Mechanisms Underlying Crbn-Sall4-Linked Thalidomide Embryopathy
by: Thayne Woycinck Kowalski, et al.
Published: (2021-06-01)

Effect of P-glycoprotein Inhibitor (Carvedilol) on Developmental Outcome Methotrexate are Given Alone and in Combination of Pregnant Rats
by: Zaid K Shnawa, et al.
Published: (2022-12-01)

The roles of glutathione peroxidases during embryo development
by: Christoph eUfer, et al.
Published: (2011-07-01)

Punicalagin improves chorioallantoic and yolk sac vasculogenesis and teratogenesis of embryos induced by nicotine exposure
by: Chunmei Lin, et al.
Published: (2015-10-01)

COVID-19 during pregnancy and adverse outcomes: Concerns and recommendations from The Brazilian Teratology Information Service
by: Fernanda Sales Luiz Vianna, et al.
Published: (2021-03-01)

Tratamiento de la mielofibrosis idiopática crónica con bajas dosis de talidomida.: Comunicación de 2 casos Treatment of chronic idiopathic myelofibrosis with talidomide low doses.: Report of 2 cases
by: Onel M. Ávila Cabrera, et al.
Published: (2010-08-01)

Angiogenesis and Melanoma
by: Vito Longo, et al.
Published: (2010-02-01)